Embree Financial Group's Significant ETF Purchases and Sales in Q2 2026
Embree Financial Group managed substantial changes to its portfolio during the quarter ending June 30, 2026. Key holdings like SCHWAB STRATEGIC TR (SCHX) saw significant reductions while others such as ISHARES TR (IVV) experienced large increases.
As of Embree Financial Group's latest filing dated June 30, 2026, the investment firm demonstrated active management of its substantial portfolio valued at $870.1 million.
The investor's strategy involved notable adjustments across various sectors and specific actions on certain holdings:
- Embree sold shares in SCHWAB STRATEGIC TR (SCHX), ISHARES TR (IVW), SCHWAB STRATEGIC TR (SCHB), and SCHWAB STRATEGIC TR (SCHV). These sales resulted in percentage changes of -14.69%, -70.79%, -22.76%, and -38.49% respectively.
- Conversely, the firm purchased significant quantities of ISHARES TR (IVV), SCHWAB STRATEGIC TR (SHLD), ISHARES TR (IWF), ISHARES TR (HDV), and INVESCO EXCH TRADED FD TR II (IDMO). The increases were substantial: 141.38%, 64.03%, 300.1%, 438.35%, and 62.41% respectively.
- Additionally, Embree added new positions with purchases of ISHARES TR (HDV) and INVESCO EXCH TRADED FD TR II (IDMO).
The most significant purchase during the quarter was in ISHARES TR (IVV), where Embree increased its stake by a remarkable 141.38%. This ETF, known for tracking the S&P 500 via SPDR shares, saw its portfolio allocation rise to 4.73%. The substantial increase in holdings suggests strong confidence in broad US market performance.
The investor also showed significant interest in adding exposure through other Exchange Traded Funds (ETFs). Embree purchased a large amount of SCHWAB STRATEGIC TR (SHLD), increasing its stake by 64.03% and allocating it 0.78%. Furthermore, the firm acquired ISHARES TR (IWF) with a 300.1% increase in shares, boosting its allocation to 0.73. These moves point towards diversification or tactical adjustments within specific asset classes.
In addition, Embree Financial Group added two new positions: ISHARES TR (HDV) and INVESCO EXCH TRADED FD TR II (IDMO). The former saw a 438.35% increase in shares, while the latter experienced a 62.41% jump.
On the selling side, Embree disposed of several holdings that showed significant changes from the previous period:
- The firm sold SCHWAB STRATEGIC TR (SCHX), which was one of its top holdings previously but saw a -14.69% change in shares.
- ISHARES TR (IVW) experienced an 80.21% reduction, effectively exiting the position almost entirely (-70.79%) while also selling SCHWAB STRATEGIC TR (SCHB) and SCHWAB STRATEGIC TR (SCHV).
- Interestingly, despite these sales, Embree's Technology sector allocation actually increased slightly due to other purchases offsetting the loss of IVW.
The overall portfolio turnover rate appears high given the number of positions changed and the magnitude of some transactions. This active approach resulted in 250 holdings being modified during this period.